Key facts
- Crescita Therapeutics shareholders will receive $0.80 per share.
- The payment is part of an arrangement with ClinActiv Holdings Inc.
- The Purchaser will acquire all Crescita shares for all-cash consideration.
- The arrangement agreement was dated March 14, 2026.
Crescita Therapeutics Inc. is a biopharmaceutical company. ClinActiv Holdings Inc. is acquiring Crescita Therapeutics through a plan of arrangement, which involves the purchase of all outstanding shares for cash.